Reconstitution of Hematopoiesis after High-Dose Chemotherapy by Autologous Progenitor Cells Generated ex Vivo
Open Access
- 3 August 1995
- journal article
- retracted article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 333 (5), 283-287
- https://doi.org/10.1056/nejm199508033330503
Abstract
Autologous peripheral-blood progenitor cells can restore hematopoiesis after high-dose chemotherapy in patients with solid tumors or hematologic cancers. We investigated the ability of peripheral-blood progenitor cells generated ex vivo to restore hematopoiesis in patients with cancer who have undergone high-dose chemotherapy.Keywords
This publication has 11 references indexed in Scilit:
- Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicinBlood, 1994
- Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cellsBlood, 1994
- Release of tumor cells from bone marrow [editorial; comment]Blood, 1994
- Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]Blood, 1994
- Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.Journal of Clinical Oncology, 1994
- Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patientsThe Lancet, 1993
- Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatinBritish Journal of Haematology, 1993
- Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietinBlood, 1993
- Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyThe Lancet, 1992
- The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies [editorial]Blood, 1991